Clinical Trial Update: A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Phase 2 feasibility study assessing N-acetylcysteine for self-injurious behavior in children with autism spectrum disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Emory University | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-12-16